caspase-1 inhibitors (Edelris SAS/Galderma Research & Development SNC/BioSolveIT/Synchrotron Soleil)
N/A
Report date: 2025/01/26 17:42:03
NME
Base Information
Drug Namecaspase-1 inhibitors (Edelris SAS/Galderma Research & Development SNC/BioSolveIT/Synchrotron Soleil)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEdelris SAS
China Registration ClassN/A
Develop Information
Active CompaniesBioSolveIT GmbHSynchrotron SOLEILEdelris SAS +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A